Radionuclide Methods for Pain Palliation
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 1
Abstract
Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and results in serious symptoms and complications such as bone pain, pathological fractures, spinal cord compression, and malignant hypercalcemia. Therefore, appropriate approach to bone metastases is important. Radionuclide therapy is characterized by the reasonably selective delivery of therapeutic doses of radiation systemically to target tissues, with generally limited toxicity and few long-term side effects. Radionuclide therapy using bone-specific radiopharmaceuticals is a safe and effective therapy for bone pain palliation in metastatic bone disease, mainly prostate cancer. Although the additive value of β-emitting radionuclides on survival is debatable, the combination of radionuclide therapy with other therapies such as chemotherapy or external radiation therapy may improve patient survival. 223-Ra, which is an alpha-emitting agent, is a radiopharmaceutical with proven efficacy in pain palliation and survival in metastatic prostate carcinoma.
Authors and Affiliations
Mine Araz, Pınar Akkuş
Keywords
Related Articles
- EP ID EP685346
- DOI 10.4274/nts.galenos.2020.005
- Views 180
- Downloads 0
How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?
Many aspects of patient management in thyroid cancers including I-131 use are based on retrospective data or expert opinions and still debatable. With the increasing use of ultrasonography, demographics of thyroid cancer...
Renal Toxicity After Radionuclide Therapy
With the introduction of radionuclide therapies, the probability of toxicity has increased in critical organs such as kidney and bone marrow. Although these toxicity rates are relatively low in targeted therapies such as...
Procedure Guidelines for Lu-177 PSMA Radyoligand Treatment
Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and PSMA-directed radioligand therapy (RLT) with Lutetium-177 (Lu-177) PSMA is promising systemic modality, which involves the delivery of t...
Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma
Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact i...
The Expectations of Pediatric Urologists from Nuclear Medicine
Nuclear medicine is frequently used by pediatric urologists. Treatment planning of ureterovesical junction obstruction, vesicoureteral reflux, and similar common congenital anomalies can only be done with well-reported n...